tbuckley/cabot-search huggingface dataset:
Preemptive Therapy with Venetoclax for High-Risk Stage a CLL Patients: First Analysis of Prevene, a Phase II Trial of the Filo Group
Authors: Luc-Matthieu Fornecker, Rémi Letestu, Nanthara Shritaran, Emmanuelle Ferrant, Fressia Honeyman, Therese Aurran-Schleinitz, Fatiha Merabet, Pierre Morel, Abderrazak El Yamani, Jehan Dupuis, Kamel Laribi, Stephane Lepretre, Lysiane Molina, Hugo Legendre, Chadi Al Nawakil, Bruno Villemagne, Anne-Sophie Michallet, Béatrice Mahé, Omar Benbrahim, Laurence Sanhes, Caroline Dartigeas, Aline Clavert, Vincent Levy
Journal: Blood (2024)
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with R-GemOx: A Multi-Center Retrospective Cohort Study
Authors: Samuel Yamshon, Jean L. Koff, Melissa C. Larson, Brad S. Kahl, Carla Casulo, Izidore S. Lossos, Sara Haddadi, Michele D. Stanchina, Dai Chihara, Amy A. Ayers, Thomas M. Habermann, Yucai Wang, Arushi Khurana, Grzegorz S. Nowakowski, Tanner W Reicks, Umar Farooq, Brian K. Link, Jonathon B. Cohen, Peter Martin, Jia Li, Ashwini Shewade, Connie Lee Batlevi, Andrea Lo-Rossi, David Fox, Anthony Masaquel, Yong Mun, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Loretta Nastoupil
Journal: Blood (2024)
Comparative Efficacy of Zanubrutinib Plus Obinutuzumab Versus Last Prior Treatment in Relapsed/Refractory Follicular Lymphoma: Growth Modulation Index Analysis from ROSEWOOD Study
Authors: Judith Trotman, Pier Luigi Zinzani, Krimo Bouabdallah, Shanmei Liao, Adam Greenbaum, Laura Dima, Laurent Dumartin
Journal: Blood (2024)
Clinicopathological and Gene Expression Analysis of Hyaline Vascular Castleman Disease
Authors: Midori Filiz Nishimura, Yoshito Nishimura, Yuika Iwamoto, Tomoka Haratake, Hideki Ujiie, Asami Nishikori, Thomas M. Habermann, Angela Dispenzieri, Yasuharu Sato
Journal: Blood (2024)
PTBP1, an RNA Binding Protein and Splicing Regulator, Binds RUNX1 and Co-Localizes at Target Gene Promoters in Leukemia
Authors: Arjun Dhir, Alexander Ethell, Kevin Tur-Rodriguez, Jim Persinger, Michelle Becker, Abu Rafay, Vikas Kumar, Sandipan Brahma, Jordan Rowley, R. Katherine Hyde
Journal: Blood (2024)
Incidence and Prevalence of Clinically Detected Smoldering Multiple Myeloma Among the General Population
Authors: Victor H. Jimenez-Zepeda, Irwindeep Sandhu, Michael P. Chu, Kathryn Rankin, Arleigh McCurdy, Hyra Sapru, Christopher Cipkar, Edward Koo, Benjamin Patrick, Sarah Albert, Meriem Henia, Christopher McCudden, Alissa Visram
Journal: Blood (2024)
Epcoritamab Induces in Vitro-Derived Terminally Differentiated Exhausted T Cells to Kill B Cells
Authors: Daisy Lin, Vanessa Spires, Jeremy Gale, Nathan Cheadle, Tine Casneuf, Gregg Masters, Lisa Grimm, Omar Jabado, Tahamtan Ahmadi, Mark Fereshteh, Maria Jure-Kunkel, Andrew J. Steele, Jordan Blum
Journal: Blood (2024)
Deep and Sustained Responses in Patients with CLL Treated with Zanubrutinib or Zanubrutinib + Obinutuzumab in Phase 1/2 AU-003 and Phase 1b GA-101 Studies: A Report from the Zanubrutinib Extension Study
Authors: Constantine S. Tam, Stephen S. Opat, Eileen Grace Merriman, Jan A. Burger, Emma Verner, Paula Marlton, David Gottlieb, Ian W. Flinn, Sumit Madan, Matthew Ku, Radha Prathikanti, Heather Allewelt, Tian Tian, Remus Vezan, Gavin Cull
Journal: Blood (2024)
Initiating First-Line (1L) Fixed-Duration (FD) Ibrutinib and Venetoclax (Ibr+Ven) in Patients (Pts) with Chronic Lymphocytic Leukemia (CLL) Improves Overall Survival (OS) Outcomes to Rates Approximating an Age-Matched General European Population
Authors: Paolo Ghia, Loic Ysebaert, Ann Janssens, Mohamed Fouad, Claudio Schioppa, Jose-Angel Hernandez Rivas, Alessandra Tedeschi
Journal: Blood (2024)
Evaluating Full Antitumor Activities of Monoclonal Antibody and Innate Immune Cells in Relapsed/Refractory Mantle Cell Lymphoma Using <i>Ex Vivo</i> Organoid Platform
Authors: Lei Nie, Vivian Jiang, Yang Liu, Tianci Zhang, Hong Kim, Jovanny Vargas, Qingsong Cai, Selvi Thirumurthi, David Santos, Michael Wang
Journal: Blood (2024)
STAT3-VDAC1 Axis Modulates Mitochondrial Function and Plays a Critical Role in the Survival of Leukemic Stem Cells
Authors: Kellen B Gil, Jamie Borg, Rosana Moreira Pereira, Anagha Inguva Sheth, Jeremy Rahkola, William Showers, Angelo D'Alessandro, Christine M. McMahon, Daniel A Pollyea, Austin E Gillen, Maria L Amaya
Journal: Blood (2024)
Treatment-Emergent Cardiovascular Events Among Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Treated with Bruton's Tyrosine Kinase Inhibitors (BTKi)
Authors: Jing-Zhou Hou, Rushir Choksi, Anupama Vasudevan, Anna Rui, Poras Davé, Mike Gart, Brandon Wang, Prateesh Varughese, Simon Blanc
Journal: Blood (2024)
Safety, Efficacy, and Pharmacokinetics of Unecritinib (TQ-B3101) in Pediatric Patients with Relapsed/Refractory Anaplastic Lymphoma Kinase Positive Anaplastic Large Cell Lymphoma: A Phase I Study
Authors: Suying Lu, Junting Huang, Ruiqing Cai, Yan Gao, Jia Zhu, Juan Wang, Yi Que, Zi-Jun Zhen, Feifei Sun, Huiqiang Huang, Yizhuo Zhang
Journal: Blood (2024)
OPN-6602, an Orally Bioavailable EP300/CBP Bromodomain Inhibitor, Targets Multiple Myeloma through Suppression of IRF4 and MYC
Authors: Bernice Matusow, Sadegh Saghafinia, Pei Pei Li, Amanda Kohler, Pan-Yu Chen, Christine Nichols, Parmveer Singh, Kerry Inokuchi, Jackie M. Walling, Gideon Bollag
Journal: Blood (2024)
Health-Related Quality of Life of Luspatercept Versus Epoetin Alfa in Red Blood Cell Transfusion-Dependent Lower-Risk Myelodysplastic Syndromes: Results from the Final Datacut of the Phase 3 COMMANDS Study
Authors: Esther Natalie Oliva, Uwe Platzbecker, Matteo Giovanni Della Porta, Guillermo Garcia-Manero, Valeria Santini, Pierre Fenaux, Jake Shortt, Rami S. Komrokji, Christopher G. Pelligra, Shien Guo, Aylin Yucel, Mrudula B. Glassberg, Laurie Eliason, Ahmed Hnoosh, Dimana Miteva, Shelo Rose, Sandra Kreitz, Mikkael A. Sekeres, Amer M. Zeidan
Journal: Blood (2024)
Assessing the Efficacy and Safety of Reduced Dexamethasone Duration in Newly Diagnosed AL Amyloidosis Versus Standard Therapy
Authors: John Hanna, Ryan Brown, Zain Ali Burney, Kawther Abdallah, Jason Valent, Christy J. Samaras, Faiz Anwer, Jack Khouri, Louis Williams, Shahzad Raza, Willem Van Heeckeren, Sandra Mazzoni
Journal: Blood (2024)
Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors: 5-Year Update of a Phase 2 Open Label Monocentric Study
Authors: Federica Colombo, Andrea Aroldi, Stefano Crippa, Federica Cocito, Luca Guerra, Lavinia Monaco, Bianca Maria Granelli, Lara Mussolin, Carlo Gambacorti-Passerini
Journal: Blood (2024)
Prior Bendamustine (Benda) Exposure Did Not Impact Clinical Outcomes and Decreased CD4+ but Not CD8+ T-Cells in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with the Bispecific Antibody Epcoritamab (Epcor)
Authors: Tycel J. Phillips, Michael Roost Clausen, Wojciech Jurczak, Tae Min Kim, Kim Linton, Chan Y Cheah, Jieying Jiang, Kubra Karagoz, Mohammad Atiya, Christian Eskelund, Han Si, Edith Szafer Glusman, Andrew J. Steele, Charles Kearns, Catherine Thieblemont
Journal: Blood (2024)
Depletion of CD59 Inhibits the Proliferation and Survival of Acute Myeloid Leukemia Cells By Altering Lipid Raft Composition and Suppression of Raf/MEK/ERK Signaling
Authors: Abdula Maher, Severine Cathelin, Dhanoop Manikoth Ayyathan, Yitong Yang, Alex Liu, Mohsen Hosseini, Steven M. Chan
Journal: Blood (2024)
Time-Limited of Zanubrutinib, Rituximab and Lenalidomide (ZR2) Regimen for the Treatment of Super-Elderly Diffuse Large B-Cell Lymphoma (DLBCL): A Prospective, Exploratory Clinical Study
Authors: Jie Zou, Xiaoning Yu, Xiaoxia Chu, Ji Ma, Zengjun Li, Chunyan Chen, Yan Liu, Jian Xing, Zhongliang Sun, Chunyan Ji, Jie Li
Journal: Blood (2024)
Spatial Multi-Omics Treatment Paradigms in a Phase II Clinical Study of Early Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: Meijuan Wu, Xi Chen, Jialiang Lu, Weihao Zhuang, Chang He, Cong Li, Haifeng Yu, Tao Lei, Xiaowu Dong, Jianpeng Sheng, Haiyan Yang
Journal: Blood (2024)
Proteomic Determinants of Renal Organ Response in AL Amyloidosis
Authors: Matthew James Rees, Eli Muchtar, Suheil Albert Atallah-Yunes, Surendra Dasari, Nelson Leung, Morie A. Gertz, Angela Dispenzieri, Ellen McPhail, Shaji Kumar, Emilie Anderson, Christopher Dick, Taxiarchis Kourelis
Journal: Blood (2024)
The Presence of <i>SH2B3</i> mutations Identifies a Distinct Subtype of Myelodysplastic Neoplasms
Authors: Maria Julia Montoro, Pamela Acha, Manja Meggendorfer, Najla H Al Ali, Víctor Navarro, Sherry Pierce, Carlos Bravo-Perez, Marie Adeline Migeon, Mestre Julia, Klaus H Metzeler, Michael Wulfert, Andres Jerez, Marina Díaz-Beyá, Beate Betz, Emmanuelle Clappier, Mar Tormo, Helena Pomares, Mónica Del Rey, Silvia Saumell, Laura Barbero, María Eugenia Rivero, Maria Diez-Campelo, David Sallman, Teresa Ezponda, Weina Chen, Zhuoer Xie, Francesc Bosch, Ulrich Germing, Uwe Platzbecker, Francesc Sole, Pierre Fenaux, Jaroslaw Maciejewski, Guillermo Garcia-Manero, Rami S. Komrokji, Torsten Haferlach, David Valcarcel
Journal: Blood (2024)
Long-Term Efficacy and Safety of Odronextamab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Pooled Analysis from the ELM-1 and ELM-2 Studies
Authors: John N. Allan, Jennifer L. Crombie, Matthew Matasar, Max S. Topp, Jan Walewski, Tae Min Kim, Won-Seog Kim, Yuan Cheng, Dina Flink, Bertha Fearon Chalet, Hesham Mohamed, Srikanth Ambati, Aafia Chaudhry, Jon E. Arnason
Journal: Blood (2024)
Modulating mRNA Translation Fidelity As a Novel Mechanism for AML Chemoresistance
Authors: Christina Mayerhofer, Dan Li, Trine A. Kristiansen, Ernst Mayerhofer, Azeem Sharda, Lingli He, Michael Mazzola, Giulia Schiroli, Karin Gustafsson, Sam Keyes, Anna Kiem, Eve Crompton, Yanxin Xu, Zhixun Dou, Charles Vidoudez, Peter G. Miller, Nick Van Gastel, David Scadden
Journal: Blood (2024)
The Exportin, CSE1L, Regulates Ribosome Biogenesis and Is a Selective Dependency in Childhood and Young Adult Acute Myeloid Leukemia
Authors: Grace Egan, Amit Kumar, Veronique Voisin, Rose Hurren, Ali Chegini, Dakai Ling, Geethu Emily Thomas, Youngran Yan, Yue Feng, Suraj Bansal, Andy G.X. Zeng, Andrea Arruda, John Edgar Dick, Gary D Bader, Mark D. Minden, Aaron D Schimmer
Journal: Blood (2024)
A Novel Segmentation-Based Purity-Informed Approach Accurately Detects Total Copy Number and Its Subclonal Fraction in Myeloma Targeted Panel Sequencing Data
Authors: Naser Ansari-Pour, Mohammad Kazeroun, Seyed Alireza Hasheminasab, Emma J Lyon, Bethan Hudson-Lund, Evie Fitzsimons, Gaurav Agarwal, Kara-Louise Royle, Matthew W. Jenner, Martin F Kaiser, Karthik Ramasamy, Kwee Yong, Eileen M Boyle, Sarah Gooding, Angela Hamblin, Anjan Thakurta
Journal: Blood (2024)
Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-up and Selected High-Risk Subgroup Analyses of the Linker-MM1 Study
Authors: Mansi R. Shah, Joshua Richter, Hans C. Lee, Attaya Suvannasankha, James E. Hoffman, Suzanne Lentzsch, Sundar Jagannath, Jeffrey A. Zonder, Rachid Baz, Swathi Namburi, Ka Lung Wu, Madhav V. Dhodapkar, Joseph J. Maly, Rebecca Silbermann, Chang-Ki Min, Matthew Pianko, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez-Lopez, Michelle DeVeaux, Dhruti Chokshi, Megan Seraphin, Anita Boyapati, Anasuya Hazra, Glenn S. Kroog, Kate Knorr, Naresh Bumma
Journal: Blood (2024)
Subsequent Treatment and Clinical Outcome Following Induction Therapy on a Phase II Study of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL)
Authors: Jia Ruan, Evelyn H. Orlando, Alison Moskowitz, Zhengming Chen, Neha Mehta-Shah, Lubomir Sokol, Steven Horwitz, Sarah C. Rutherford, Tejasvi Sahni, Ari M Melnick, Giorgio Inghirami, Leandro Cerchietti, John P. Leonard, Peter Martin
Journal: Blood (2024)
Novel NOTCH1 Effector NFIL3 Is a Therapeutic Target to Combat Drug Resistance and Improve Patient Outcomes in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma
Authors: Wen-Hui Cheng, Daniela Simone Maichl, Julius Arthur Kirner, Stefanie Schmidt, Carsten Patrick Ade, Mengshi Yang, Malik Salman Haider, Robert Luxenhofer, Lyudmyla Taranets, Melanie Haffner-Luntzer, Verena Fischer, Anita Ignatius, Nikita Popova, Franziska Jundt
Journal: Blood (2024)
Long-Term Follow-up from the Phase 2 ICON Study of Iberdomide Combined with Low-Dose Cyclophosphamide and Dexamethasone in Relapsed/Refractory Multiple Myeloma (IberCd)
Authors: Charlotte L.B.M. Korst, Wouter Plattel, Elizabeth de Kort, Alexandra Croockewit, Mark-David Levin, Matthijs Westerman, Okke De Weerdt, Inger S. Nijhof, Jurgen Wegman, Nina Smit, Christie P.M. Verkleij, Tuna Mutis, Marjolein van der Klift, Laurens Franssen, Kaz Groen, Ellen van der Spek, Wilfried Roeloffzen, Sonja Zweegman, Niels W.C.J. van de Donk
Journal: Blood (2024)
The Number of Extranodal Sites Matters! a Proposal for a Feasible Prognostic Model in Nodal PTCL. a <i>Collaborative Study</i> grupo De Estudio Latino-Americano De Linfoproliferativos <i>(GELL) &amp; T-Cell Brazil Project (TCBP)</i>
Authors: Thais Fischer, Eliana Miranda, Juliana Pereira, Guilherme Duffles, Jamila Vaz Tavarez, Nelson S Castro, Rodrigo Santucci, Danielle Leão Cordeiro De Farias, Sergio Brasil, Claudio G Macedo, Carolina Colaco, Renata Lyrio R Baptista, Karin Z Cecyn, Davimar Bortucchi, Gilnara Fontinele Silva, Samir Nabhan, Patricia Giacon, Rony Schaffel, Natalia Pin Chuen Zing, Frederico Lisboa Nogueira, Ademar Dantas Cunha, Diego Vila Cle, Jose D Tadeu, Vera Figueiredo, Mateus Dalló Dal Pont, Rafael Gaiolla, Nelson Hamerschlak, Eduardo Flavio Oliveira Ribeiro, Abrahão Elias Hallack Neto, Maria Almeida Dias, Yung Gonzaga, Yana S Rabelo, Larissa Lane Teixeira, Guilherme Fleury Perini, Milene Matedi, Priscilla Cury, Henry Idrobo, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valverte, Luis Mario Villela Martinez, Ana Carolina Oliver, Laura Korin, Camila Peña, Macarena Roa, Maria Alejandra Torres, Seisha Alana von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Casey Bermack, Kelly Meza, Bryan Valcarcel, Carmino A Souza, Luis Malpica, Carlos Chiattone
Journal: Blood (2024)
Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 Study)
Authors: Huayuan Zhu, Yi Miao, Shuchao Qin, Ming Liu, Yi Xia, Luomengjia Dai, Tonglu Qiu, Chong-Yang Ding, Hairong Qiu, Chun Qiao, Yujie Wu, Fei Li, Xiao Lu, Wei Xu, Lei Fan, Jianyong Li
Journal: Blood (2024)
Prognostic Impact of Measurable Residual Disease Evaluated By Next Generation Flow and PET-CT in Clinical Practice at Fundación Santa Fe De Bogotá Hospital, Colombia
Authors: Martha Romero Prieto, Andrés Melo Arias, Juan Guio Oros, Natalia Tijaro Ovalle, Gonzalo Ucros, Karen Galvis, Diana Martinez, Gina Cuellar, Carlos Saavedra, Liliana Martin, Sandra Quijano, Andres Borda Molina, Guillermo Quintero, Mónica Duarte, Juanita Zuluaga Castro, Julian Cubillo, Viviana Barrera, Claudia Agudelo, Carmenza Camargo, Beatriz Wills, Luis Buitrago, Marco Paez, Oscar Torres, Oscar Rivero, Joaquin Martínez-López, Patricia Bernal
Journal: Blood (2024)
Clearance of Very Low Levels of Measurable Residual Disease with Blinatumomab Significantly Improves Outcomes in B-Cell Acute Lymphoblastic Leukemia
Authors: Daniel Nguyen, Elias Jabbour, Nitin Jain, Omer Karrar, Cedric Nasnas, Fadi G. Haddad, Jayastu Senapati, Tapan M. Kadia, Rebecca Garris, Hagop M. Kantarjian, Nicholas J. Short
Journal: Blood (2024)
Interferon-Activated Gene Signatures Associate with Chemotherapy Resistance and Sensitivity to JAK-Inhibition in Refractory ETP-ALL
Authors: Jason Xu, Jonathan Sussman, Austin Yang, Satoshi Yoshimura, Changya Chen, Omar Elghawy, Tiffaney Vincent, Caroline Diorio, Shovik Bandyopadyay, Jianzhong Hu, Alexander Lai Li, Gregory M. Chen, Chia-Hui Chen, Rawan Shraim, Haley Newman, Yang Ding, Elizabeth Li, Wenbao Yu, Anusha Thadi, Kyung Jin Ahn, Petri Pölönen, Abdelrahman Elsayed, David Frank, Elizabeth A. Raetz, Mignon L. Loh, Brent L. Wood, Stuart S. Winter, Kimberly P. Dunsmore, Meenakshi Devidas, Chunxu Qu, Stanley Pounds, Stephen P. Hunger, Charles G. Mullighan, Jun J. Yang, Kai Tan, David T. Teachey
Journal: Blood (2024)
Cell-Intrinsic and Immune-Mediated Effects in Lymphoma Patients Treated with Golcadomide and Associations with Treatment Outcome
Authors: Soraya Carrancio, Jessica Voetsch, Alberto Risueño, Carla Guarinos, Siddhesh Kulkarni, Mandeep Takhar, Matthew E. Stokes, Bérengère de Moucheron, Laura Furman, Julio C. Chavez, Jean-Marie Michot, Loretta Nastoupil, Daniel W. Pierce, Danielle Greenawalt, Michael Pourdehnad
Journal: Blood (2024)
Dose-Dense Brentuximab Vedotin Plus Ifosfamide, Carboplatin, and Etoposide (ICE) in Second Line Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma: 5-Year Long Term Follow up
Authors: Ryan C. Lynch, Ryan D. Cassaday, Stephen D. Smith, Andrew J. Cowan, Edus H. Warren, Mazyar Shadman, Brian G. Till, Chaitra S. Ujjani, Karolyn Morris, Heather Rasmussen, Jenna M. Voutsinas, Ajay K. Gopal
Journal: Blood (2024)
Safety of Venetoclax Ramp-up before CD20 Antibody Administration in Chronic Lymphocytic Leukemia
Authors: Emelie Curovic Rotbain, Mikkel Werling, Casper Møller Frederiksen, Christian Bjørn Poulsen, Martin Hutchings, Caspar Da Cunha-Bang, Carsten Utoft Niemann
Journal: Blood (2024)
Anchored Matching Adjusted Indirect Treatment Comparison of Quizartinib Vs Midostaurin in Newly Diagnosed Patients with FLT3-ITD-Positive Acute Myeloid Leukaemia
Authors: Nishan Shaik, Harry P. Erba, Sudhir Unni, Svenja Petersohn, Elizabeth Westerberg, Boris Gorsh, Akash Nahar, Kristy Burns, Sonja Kroep
Journal: Blood (2024)
Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial
Authors: Paul J. Bröckelmann, Sophie Teesink, Lydia Visser, Conrad-Amadeus Voltin, Helen Kaul, Hans Schlösser, Bart-Jan Kroesen, Carsten Kobe, Peter Borchmann, Arjan Diepstra, Wouter Plattel
Journal: Blood (2024)
Mapping T-ALL to T Cell Differentiation Trajectory Identifies an ETP-like Subgroup Arrested at an Early Stage of T Cell Development
Authors: Heye Yu, Wenbing Liu, Junping Zhang, Leling Xie, Anli Lai, Zheng Tian, Kejing Tang, Haiyan Xing, Wang Ying, Hui Wei, Qing Rao, Runxia Gu, Min Wang, Huijun Wang, Jianxiang Wang, Shaowei Qiu
Journal: Blood (2024)
Full Spectrum Multi-Parameter Single-Tube Flow Cytometry Analysis for Cross-Sectional Immune-Profiling of Natural Killer Cells in Multiple Myeloma Clinical Samples
Authors: Arghya Ray, Yan Song, Ting Du, Leutz Buon, Md. Abu Musa, Xueping Wan, Sindhu C Pillai, Teng Fang, Minxing Wang, Dharminder Chauhan, Kenneth C. Anderson
Journal: Blood (2024)
Functional Genomics Studies Decipher the Genetic Perturbations and Unravel Mechanisms of Response/Resistance upon Mutant-Specific KRAS Inhibition in Multiple Myeloma
Authors: Torsten Steinbrunn, Ryosuke Shirasaki, Olga Dashevsky, Huihui Tang, Shizuka Yamano, Phaik Ju Teoh, Lisa Leypoldt, Brian Glassner, Ricardo De Matos Simoes, James Christensen, Constantine S Mitsiades
Journal: Blood (2024)
An Erythroid-Specific Lentiviral Vector Improves Anemia and Iron Metabolism in a New Model of Xlsa
Authors: Carlo Castruccio Castracani, Laura Breda, Tyler E. Papp, Amaliris Guerra, Enrico Radaelli, Charles-Antoine Assenmacher, Giovanni Finesso, Barbara Mui, Ying K. Tam, Simona Fontana, Chiara Riganti, Veronica Fiorito, Sara Petrillo, Emanuela Tolosano, Hamideh Parhiz, Stefano Rivella
Journal: Blood (2024)
Relieving Restriction in Resting CD8+ T Cells Increases Gene Transfer and Improves Tumor Killing after Transduction with CD8-Targeted CD19CAR Fusosome
Authors: Mariliis Ott, Hadega Aamer, Daryl Humes, Reuben Burch, Christina Proano, Brian Dolinski, Diana Vedenova, Ashley Benson, Ryan White, Semih Tareen, Jesse Green, Kutlu G Elpek, Neal van Hoeven, Terry J Fry
Journal: Blood (2024)
<i>In Vivo</i> Hematopoietic Stem Cell Engineering Restores the Function of NADPH Enzyme Complex in X-Linked Chronic Granulomatous Disease Model Mice
Authors: Sravya Kattula, Gaurav M. Rajani, Vemika Chandra, Mike M. Martinez, Raissa Eluere, Patrick Au, Robert T. Peters, Joe Salas
Journal: Blood (2024)
Gene Therapy for Artemis-SCID and Artemis-Leaky-SCID Patients: Preliminary Results of the French Artegene Phase I/II Clinical Trial
Authors: Jean-Sebastien Diana, Despina Moshous, Martin Castelle, Boris Bessot, Elisa Magrin, Marwa Chbihi, Paul Bastard, Alice Girardot, Cecile Roudaut, Chloe Mollet, Clotilde Aussel, Caroline Tuchmann-Durand, Eden Schwartz, Olaf Neth, Peter Olbrich, Irene d'Alba, Jacques Riviere, Medhi Oualha, Laure Joseph, Benedicte Neven, Jean-Pierre De Villartay, Anne Galy, Chantal Lagresle-Peyrou, Marina Cavazzana
Journal: Blood (2024)
Combination Regimens in MM Post Autologous Hematopoietic Cell Transplantation (AHCT) to Eliminate MRD Utilizing Iberdomide (COMMANDER): Results of Dose-Finding Component of a Phase 1b/2 Trial
Authors: Natalie Callander, Gayathri Ravi, Rebecca W. Silbermann, Zhubin J. Gahvari, Eva Medvedova, Bhagirathbhai Dholaria, Naresh Bumma, Doris K. Hansen, Everette M Colquette, Pamela Hardwick, Luciano J. Costa
Journal: Blood (2024)
Interferon Alpha Activates the Unfolded Protein Response Resulting in Synergy with Bortezomib in <i>JAK2</i> V617F Myeloproliferative Neoplasms
Authors: Graeme Greenfield, Yu Sheng, Lisa J Crawford, Yaser Atlasi, Dan Longley, Ken I Mills, Mary Frances McMullin
Journal: Blood (2024)
Delivery of Gene Writers <i>In Vivo</i> to Hematopoietic Stem Cells and T Cells Using Targeted and Untargeted Lipid Nanoparticles (LNP)
Authors: Michael T. Monte, Lorenzo Tozzi, Rahul Palchaudhuri, Apiwat Wangweerawong, Yaser Heshmati, Giulia Schiroli, Han Gu, Yu Cao, William E. Salomon, Anne Bothmer, Jason Rodriguez, Mohit Gupta, James B. Rottman, William Querbes, Cecilia Cotta-Ramusino, Michael C Holmes, Hari Pujar, Z. Jane Wang
Journal: Blood (2024)
Impact of Absolute Lymphocyte Count at Pre-Apheresis and Pre-Lymphodepletion on Chimeric Antigen Receptor (CAR)-T Therapy Outcomes in Relapsed Refractory Multiple Myeloma (RRMM)
Authors: Noriko Nishimura, Sham Mailankody, Samantha Brown, Sean M. Devlin, Bruno Almeida Costa, Tasmin Farzana, Eric M Jurgens, Ross S Firestone, Karthik Nath, David J. Chung, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Roni Shouval, Hamza Hashmi, Hani Hassoun, Kylee H Maclachlan, Malin Hultcrantz, Neha Korde, Alexander M. Lesokhin, Urvi A. Shah, Carlyn Rose Tan, Sergio A. Giralt, Saad Z. Usmani, Sridevi Rajeeve
Journal: Blood (2024)
Inferior Survival in Double Refractory Large B-Cell Lymphoma Eligible for Third-Line CD19 Chimeric Antigen T-Cell Therapy
Authors: Chathuri Abeyakoon, Sita D. Bhella, Katrina Hueniken, Rachel Aitken, Carmel Waldron, Anca Prica, Vishal Kukreti, Robert Kridel, Abi Vijenthira, Christine I Chen, Chloe Yang, Richard Tsang, David Hodgson, Danielle Rodin, Nauman Malik, Woodrow Wells, Michael Crump, John Kuruvilla
Journal: Blood (2024)
Tagraxofusp Achieves Anti-Tumor Activity with Rapid Restoration of Normal Hematopoiesis in Treatment-Naïve Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Subanalysis of a Pivotal Trial
Authors: Marina Konopleva, Naveen Pemmaraju, Kendra L. Sweet, Anthony S. Stein, David A. Rizzieri, Eunice S. Wang, Sumithira Vasu, Todd Rosenblat, Michael Zuurman, Ira Gupta, Andrew A. Lane
Journal: Blood (2024)
Clonotype-Naïve Detection of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)
Authors: Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Pooja Phull, Noa Biran, David H. Vesole, Harsh Parmar, Andrew L Pecora, Andrew Ip, Andre Goy, David S. Siegel
Journal: Blood (2024)
Endothelial Activation and Stress Index (EASIX) to Predict Survival in T or NK Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis
Authors: Wenyu Shi, Yi Miao, Jianyong Li, Jing Zhang, Xuzhang Lu, Bingzong Li, Chunling Wang, Yun Zhuang, Yuqing Miao, Haiwen Ni, Xiaoyan Xie, Jingyan Xu, Yunping Zhang, Min Zhao, Min Xu, Wanchuan Zhuang, Weiying Gu, Guoqiang Lin, Haiying Hua, Jianfeng Zhu, Maozhong Xu, Tao Jia, Ping Liu, Lijia Zhai
Journal: Blood (2024)